Achieving Better Health Outcomes Through Health Equity and Patient-Centered Approaches

Health equity and patient-centricity are both increasingly being considered by pharma companies according to the drug development pipeline. In a new sponsored Fierce Pharma article, Kelvin Tan of Jazz Pharmaceuticals discusses how the company has prioritized these efforts in their oncology and neuroscience projects by advocating for health literacy and patient input.

According to Tan, “My role at Jazz is to make sure the patient voice is heard loud and clear throughout our R&D process, starting with early drug discovery through to when our medicines are on the market reaching larger populations in real-world settings. Jazz has a longstanding commitment to developing life-changing medicines for people affected by serious diseases for which current therapies are lacking. This begins with listening to patients to understand and reflect their needs in our R&D priorities and throughout all stages of the drug development lifecycle.”

To read more, click here.

(Source: Fierce Pharma, November 7^th, 2022)